Sean Duffy plans $0.53M Omada Health share sale

Omada Health, Inc. (OMDA) received a notice under Rule 144 from Sean Duffy indicating an intention to sell up to 21,572 shares of common stock.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) received a notice under Rule 144 from Sean Duffy indicating an intention to sell up to 21,572 shares of common stock. These shares are to be acquired through the exercise of stock options for cash on 09/01/2026, with Morgan Stanley Smith Barney LLC listed as broker and the stock traded on NASDAQ.

The notice also lists multiple prior Rule 10b5-1 plan sales of Omada common stock by Sean Duffy over the past three months, with individual transactions ranging from a few hundred shares to nearly fifteen thousand shares on specific June–August 2026 dates.

Key Figures

Shares to be sold: 21,572 shares Aggregate market value of planned sale: $529,592.60 10b5-1 sale on 08/10/2026: 12,942 shares for $321,058.67 +2 more

5 metrics

Shares to be sold 21,572 shares Planned Rule 144 sale of Omada Health common stock

Aggregate market value of planned sale $529,592.60 Value associated with 21,572 shares of Omada Health common stock

10b5-1 sale on 08/10/2026 12,942 shares for $321,058.67 Rule 10b5-1 sale of Omada Health common stock by Sean Duffy

10b5-1 sale on 08/03/2026 12,944 shares for $264,007.12 Rule 10b5-1 sale of Omada Health common stock by Sean Duffy

10b5-1 sale on 06/16/2026 14,960 shares for $259,711.58 Rule 10b5-1 sale of Omada Health common stock by Sean Duffy

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 09/01/2026 | Exercise of Stock Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Sean Duffy Rule 144 notice for Omada Health (OMDA) disclose?

The notice states that Sean Duffy plans to sell up to 21,572 shares of Omada Health common stock, to be acquired by exercising stock options for cash on 09/01/2026, with Morgan Stanley Smith Barney LLC as broker and the shares listed on NASDAQ.

How many Omada Health (OMDA) shares are covered by the planned sale?

The planned transaction covers 21,572 shares of Omada Health common stock. The notice lists an aggregate market value of $529,592.60 for these shares in the securities information section.

How will Sean Duffy acquire the Omada Health (OMDA) shares to be sold?

Sean Duffy plans to acquire the 21,572 shares of Omada Health common stock through the exercise of stock options from the issuer, with the consideration listed as cash and an acquisition date of 09/01/2026.

What recent 10b5-1 plan sales of Omada Health (OMDA) shares are listed?

The notice lists several 10b5-1 sales, including 12,942 shares for $321,058.67 on 08/10/2026 and 12,944 shares for $264,007.12 on 08/03/2026, along with additional June–July 2026 transactions.

Who is the broker for the planned Omada Health (OMDA) share sale?

The broker listed for the planned sale of 21,572 shares of Omada Health common stock is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

On which market is Omada Health (OMDA) common stock traded according to the notice?

The securities information section indicates that Omada Health common stock related to this Rule 144 notice is traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:41 PM EDT Accepted by SEC EDGAR 09/01/2026 - 04:40 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002069522
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Omada Health, Inc.
SEC File Number	001-42679
Address of Issuer	611 Gateway Blvd, Suite 120 South San Francisco CALIFORNIA 94080
Phone	8889878337
Name of Person for Whose Account the Securities are To Be Sold	SEAN DUFFY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21572	529592.60	61216703	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Exercise of Stock Options	Issuer			21572	09/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	08/10/2026	12942	321058.67
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	08/07/2026	8628	188521.80
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	08/03/2026	12944	264007.12
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	07/01/2026	12944	293787.38
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	07/01/2026	12942	293435.69
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/26/2026	9844	193013.28
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/26/2026	4314	90162.60
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/25/2026	300	5700.99
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/24/2026	2800	53238.92
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/16/2026	14960	259711.58

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sean Duffy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)